The above results demonstrated that CD19 may be the most critical gene affecting the immunophenotyping of pancreatic cancer, and CD19 mainly affected the occurrence and development of IS2 and IS3 immune subtypes of pancreatic cancer through B cells and T cells. Here, CD19 is linked to pancreatic neoplasm.